icotrokinra hydrochloride · Janssen Biotech · NDA 220149
Icotyde
Earliest generic entry, as listed
19 Nov 2041
Blocked by patent: US 11939361.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11939361 | drug product, use U-4447 · sets the listed date | 19 Nov 2041 |
| US 11845808 | drug substance, use U-4447 | 14 Jan 2041 |
| US 12552836 | drug substance, drug product | 12 Jul 2039 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 17 Mar 2031 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220149 · 001 · RLD | tablet, oral | EQ 200MG BASE | 19 Nov 2041 |